All treatments
Treatment
Etrasimod Arginine Blue clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingHuman Pharmacology (Phase I)- Other
C5041034 - A Phase 1, Open-Label, Randomized, Single Dose, Crossover Study to Estimate the Relative Bioavailability of Etrasimod (PF-07915503) Mini Tablets in Water and 3 Food Vehicles Compared to the Etrasimod (PF-07915503) Clinical IR Tablets Under Fasted Conditions, and to Evaluate Mini Tablet Palatability in Healthy Adult Participants
This study looks at how a new medicine, etrasimod, is absorbed by the body. We're comparing different forms of the medicine in healthy adults to see which works best and is easiest to take, especially for conditions like ulcerative colitis.
For: immune-mediated inflammatory disorders · including ulcerative colitis · alopecia areataBelgium - Ongoing, recruitingPhase II and Phase III (Integrated)
C5041006 (APD334 202 or APD334-202EU): A Multicenter, Randomized, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn’s Disease
This study is testing a new medicine called etrasimod for people with moderate to severe Crohn's disease. Researchers want to see if it helps improve symptoms and gut health, and if it is safe to use.
For: Crohn's DiseaseAustria · Denmark · Poland